logo
Plus   Neg
Share
Email

Novartis: Aimovig Shows Long-term Efficacy In Treatment Of Episodic Migraine

Novartis (NVS) reported positive results from a 4.5-year, interim analysis of a 5-year, open-label treatment period to evaluate Aimovig in patients with episodic migraine. In the study, Aimovig reduced monthly migraine days, and also lowered the number of days requiring acute migraine-specific medication. The safety profile and tolerability were in line with previous clinical data for Aimovig.

Aimovig is a EMA and FDA-approved migraine prevention treatment. Novartis and Amgen are co-commercializing Aimovig in the US. Amgen has rights to Aimovig in Japan. Novartis has rights to commercialize in the rest of the world.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon is expanding the aircraft fleet of its air cargo network by leasing 12 additional Boeing 767-300 converted cargo aircraft from Air Transport Services Group Inc. This comes amid increased demand for shipments due to the coronavirus pandemic. These aircraft will join Amazon Air's existing fleet of 70 aircraft to bring its total network to more than 80 aircraft. New York's transit agency The Metropolitan Transportation Authority or MTA has pulled its newest subway cars from service after two cars got detached from a moving train. New York City Transit Interim President Sarah Feinberg launched an investigation into the matter. The entire R179 fleet from Canadian company Bombardier Inc. has been pulled until further notice after the incident in Chambers AMC Entertainment Holdings, Inc., the world's largest theatre chain, said it has substantial doubt in its ability to continue its business as theaters across the world remain closed for months now following coronavirus or Covid-19 pandemic. In a regulatory filing, the company said it is "generating effectively no revenue", and that additional capital, if needed, may not be available.
Follow RTT